Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Guanine nucleotide binding protein (G protein) q polypeptide (GNAQ; G-ALPHA-q); calcineurin; transient receptor potential cation channel subfamily

May 21, 2015 7:00 AM UTC

Mouse studies suggest inhibiting GNAQ, calcineurin or TRPC6 could help treat focal segmental glomerulosclerosis (FSGS). In kidney podocytes, signaling between GNAQ and calcineurin activates TRPC6. In ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article